Showing results (241-250 of 361) with videos related to
Sort By:
Pageof 37
Gastroenterologie Clinique Et Biologique|April 1, 1987
[Propagation of the gastric peristalsis in normal subjects and duodenal ulcer patients]M Boiron, P Arhan, E D Dorval, et al.Blood|March 1, 1986
Treatment of hairy cell leukemia with recombinant alpha interferon: I. Quantitative study of bone marrow changes during the first months of treatmentG Flandrin, F Sigaux, S Castaigne, et al.Pathologie-Biologie|March 1, 1983
[Herpes virus infections during a remission induction treatment in acute leukemias]M Marty, C Pontus, C Scieux, et al.Tissue Antigens|November 1, 1983
HLA-A, -B, and -DR antigens in North African patients with nasopharyngeal carcinomaP Herait, T Tursz, M Y Guillard, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1993
Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinomaG Rousselet, M Bachouchi, P Busson, et al.Journal of Virology|July 25, 2000
Immune response to recombinant adenovirus in humans: capsid components from viral input are targets for vector-specific cytotoxic T lymphocytesV Molinier-Frenkel, H Gahery-Segard, M Mehtali, et al.Nature Medicine|April 15, 1999
Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivoN C Fernandez, A Lozier, C Flament, et al.Cancer Research|February 24, 1999
Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulationF Sbih-Lammali, B Clausse, H Ardila-Osorio, et al.International Journal of Cancer|April 1, 1992
Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in Epstein-Barr-virus-positive nasopharyngeal carcinoma cellsP Busson, Q Zhang, J M Guillon, et al.The EMBO Journal|September 1, 1989
EBV gene expression in an NPC-related tumourM M Hitt, M J Allday, T Hara, et al.Pageof 37